These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 29905933)
41. TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: Report of a case with a TPM3-ALK translocation. Thorner PS; Shago M; Marrano P; Shaikh F; Somers GR Pathol Res Pract; 2016 Oct; 212(10):937-942. PubMed ID: 27450657 [TBL] [Abstract][Full Text] [Related]
42. New insights in the new WHO classification of adult renal tumors. Hes O; Michalová K; Pivovarčíková K Cesk Patol; 2022; 67(4):187-191. PubMed ID: 36513503 [TBL] [Abstract][Full Text] [Related]
43. Morphologic and Immunohistochemical Characteristics of Fluorescent In Situ Hybridization Confirmed TFE3-Gene Fusion Associated Renal Cell Carcinoma: A Single Institutional Cohort. Akgul M; Saeed O; Levy D; Mann SA; Cheng L; Grignon DJ; Eble JN; Idrees MT Am J Surg Pathol; 2020 Nov; 44(11):1450-1458. PubMed ID: 32701515 [TBL] [Abstract][Full Text] [Related]
44. Re-evaluation of histological type by immunohistochemical and genetic study of transcription factors (TFE3 and TFEB) of VHL gene mutation-negative clear cell renal cell carcinoma and other special types of renal tumor. Kuroda N; Kawada C; Tamura K; Hiroi M; Hes O; Michal M; Wada Y; Inoue K; Ohara M; Mizuno K; Shuin T; Lee GH Med Mol Morphol; 2011 Mar; 44(1):46-51. PubMed ID: 21424937 [TBL] [Abstract][Full Text] [Related]
45. TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma. Xu Y; Rao Q; Xia Q; Shi S; Shi Q; Ma H; Lu Z; Chen H; Zhou X Int J Clin Exp Pathol; 2015; 8(3):2690-9. PubMed ID: 26045774 [TBL] [Abstract][Full Text] [Related]
47. The incidence of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion in Saudi adult patients with renal cancer: a retrospective tissue microarray analysis. Al-Maghrabi J; Mufti S; Gomaa W Pol J Pathol; 2018; 69(4):376-383. PubMed ID: 30786687 [TBL] [Abstract][Full Text] [Related]
48. Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma. Hayes M; Peckova K; Martinek P; Hora M; Kalusova K; Straka L; Daum O; Kokoskova B; Rotterova P; Pivovarčikova K; Branzovsky J; Dubova M; Vesela P; Michal M; Hes O Virchows Arch; 2015 Mar; 466(3):313-22. PubMed ID: 25544614 [TBL] [Abstract][Full Text] [Related]
56. TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms. Caliò A; Marletta S; Brunelli M; Pedron S; Portillo SC; Segala D; Bariani E; Gobbo S; Netto G; Martignoni G Virchows Arch; 2022 Dec; 481(6):877-891. PubMed ID: 35980471 [TBL] [Abstract][Full Text] [Related]
57. Multicystic Clear Cell Renal Tumors With Low-grade Nuclear Features: Time to Include TFE3 Translocation-associated Carcinomas. Cai Q; Gagan J; Koduru P; Cadeddu J; Shah RB; Kapur P; Palsgrove DN Adv Anat Pathol; 2024 Jan; 31(1):34-42. PubMed ID: 37937590 [TBL] [Abstract][Full Text] [Related]
58. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. Ramphal R; Pappo A; Zielenska M; Grant R; Ngan BY Am J Clin Pathol; 2006 Sep; 126(3):349-64. PubMed ID: 16880148 [TBL] [Abstract][Full Text] [Related]
59. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions: clinical experience and literature review. He J; Chen X; Gan W; Zhu B; Fan X; Guo H; Jia R Future Oncol; 2015; 11(24):3243-52. PubMed ID: 26169997 [TBL] [Abstract][Full Text] [Related]
60. [Clinicopatholigic features of renal cell carcinoma associated with chromosome X inversion harboring gene fusions involving TFE3]. Zhao YN; Wang XT; Xia QY; Wang GP; Sun SY; Zhao LF; Zhou XJ; Rao Q Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):574-579. PubMed ID: 30107660 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]